Description
Tesamorelin is a synthetic analogue of the GHRH (Growth Hormone Releasing Hormone) peptide that acts as an agonist of GHRH receptors in the anterior pituitary → pulsatile endogenous GH secretion specifically targeted to visceral lipid metabolism without inducing pharmacological tolerance or suppressing the physiological hormonal axis.
- Product authenticity can be verified by scanning the QR code on the packaging.
Warnings:
- Keep out of reach of children.
- Store in a cool, dry place.
Characteristics:
- 5 mg per vial
- 3 mL per vial
- Includes Bac Water
- Selective reduction of visceral adipose tissue (VAT) → decreased deep intra-organ abdominal fat via endogenous GH-mediated lipolysis and increased adipocyte sensitivity to catecholamines.
- Improved lipid profile and cardiovascular markers → reduced serum triglycerides, total cholesterol, and optimized HDL/LDL ratio associated with decreased metabolically active visceral fat.
- Maintenance of the physiological architecture of the GH/IGF-1 axis → preserved nocturnal pulsatile secretion that avoids side effects of continuous supraphysiological exposure (edema, insulin resistance, acromegaloid changes).
- Enhanced lean body composition → positive nitrogen protein synthesis and reduced low-grade systemic inflammation (IL-6, CRP) associated with visceral obesity.
- Neuroprotective and cognitive effect → improved executive function and working memory through activation of neurotrophic pathways (BDNF) and modulation of neuroinflammation in experimental models.





Reviews
There are no reviews yet.